GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HCW Biologics Inc (NAS:HCWB) » Definitions » Price-to-Tangible-Book

HCW Biologics (HCW Biologics) Price-to-Tangible-Book : 3.74 (As of Apr. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is HCW Biologics Price-to-Tangible-Book?

As of today (2024-04-28), HCW Biologics's share price is $1.3999. HCW Biologics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.37. Hence, HCW Biologics's Price to Tangible Book Ratio of today is 3.74.

The historical rank and industry rank for HCW Biologics's Price-to-Tangible-Book or its related term are showing as below:

HCWB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.62   Med: 1.84   Max: 3.78
Current: 3.78

During the past 5 years, HCW Biologics's highest Price to Tangible Book Ratio was 3.78. The lowest was 1.62. And the median was 1.84.

HCWB's Price-to-Tangible-Book is ranked worse than
63.36% of 1220 companies
in the Biotechnology industry
Industry Median: 2.65 vs HCWB: 3.78

A closely related ratio is called PB Ratio. As of today, HCW Biologics's share price is $1.3999. HCW Biologics's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.37. Hence, HCW Biologics's P/B Ratio of today is 3.74.


HCW Biologics Price-to-Tangible-Book Historical Data

The historical data trend for HCW Biologics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HCW Biologics Price-to-Tangible-Book Chart

HCW Biologics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - 1.62 1.84 3.28

HCW Biologics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 1.54 2.73 2.86 3.28

Competitive Comparison of HCW Biologics's Price-to-Tangible-Book

For the Biotechnology subindustry, HCW Biologics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCW Biologics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HCW Biologics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where HCW Biologics's Price-to-Tangible-Book falls into.



HCW Biologics Price-to-Tangible-Book Calculation

HCW Biologics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=1.3999/0.374
=3.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


HCW Biologics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of HCW Biologics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


HCW Biologics (HCW Biologics) Business Description

Traded in Other Exchanges
N/A
Address
2929 N Commerce Parkway, Miramar, FL, USA, 33025
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.
Executives
Gary M Winer director C/O LENSAR, INC., 2800 DISCOVERY DRIVE, ORLANDO FL 32826
Hing C Wong director, officer: Chief Executive Officer C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025
Rebecca Byam officer: Chief Financial Officer C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025
Lee Flowers officer: SVP of Business Development C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025
Rick S. Greene director C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025
Jin-an Jiao officer: VP of Development C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025
Lisa M. Giles director DURATA THERAPEUTICS, INC., 200 SOUTH WACKER DRIVE SUITE 2550, CHICAGO IL 60606
Scott T Garrett director 35 CROSBY DRIVE, BEDFORD MA 01730
Peter Rhode officer: See Remarks C/O HCW BIOLOGICS, INC., 2929 N COMMERCE PKWY, MIRAMAR FL 33025
Medmira Capital Ltd. 10 percent owner 16F BEIKE BUILDING, 59 GAOXIN NANJIU RD, SHENZHEN F4 518057

HCW Biologics (HCW Biologics) Headlines